Skip to main content

BANK OF NOVA SCOTIA

Bank

Position in NVO — Novo Nordisk A S

CIK 9631 TORONTO, A6

Position in NVO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$146,936,818
+$144,937,362 QoQ
Shares Held
3,065,015
+5533.5% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#25
of 1,348 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$1,438,200
PutShares
30,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BANK OF NOVA SCOTIA holds $1,312,781,180 across 10 Drug Manufacturers - General names. NVO ranks #4 (11.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVO
Novo Nordisk A S
This page
3,065,015 $146,936,818

All Filings in NVO

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $146,936,818 3,065,015
2026-06-30 $1,438,200 30,000
2026-03-31 $1,999,456 54,407
2025-12-31 $2,542,320 49,967
2025-12-31 $13,228 260
2025-09-30 $1,618,864 29,174
2025-09-30 $14,427 260
2025-06-30 $1,297,506 18,799
2025-03-31 $845,015 12,169
2024-12-31 $1,088,153 12,650
2024-09-30 $926,840 7,784
2023-12-31 $412,455 3,987
2023-09-30 $261,543 2,876